Retraction

MicroRNA‑101 induces apoptosis in cisplatin‑resistant gastric cancer cells by targeting VEGF‑C

Retraction Details

Citations (24)

24
Total Citations
3
Post-Retraction
(12.5%)
21
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
2 Within 1 year
1 After 2+ years
800 Days since retraction (latest)
Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers
Nasim Ebrahimi, Ali Hakimzadeh, Farima Bozorgmand et al. (11 authors)
Cell Cycle
Published: Oct 2023
4 citations
800 days after retraction
Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer
Xiaoyan Yang, Yiwen Wu, Zhizhong Xie et al. (8 authors)
Combinatorial Chemistry & High Throughput Screening
Published: Apr 2022
2 citations
237 days after retraction
The Role of miR-101 in Esophageal and Gastric Cancer
Athanasios Syllaios, Stratigoula Sakellariou, Nikolaos Garmpis et al. (10 authors)
Personalized Medicine
Published: Aug 2021
7 citations
8 days after retraction
miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway
Caijin Zhou, Linxia Chen, Rihong Chen et al. (8 authors)
Journal of Chemotherapy
Published: Jun 2021
10 citations
45 days before retraction
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
Amir Sadra Zangouei, Meysam Moghbeli
Genes and Environment Open Access
Published: Jun 2021
35 citations
63 days before retraction
A predictive model for assessing prognostic risks in gastric cancer patients using gene expression and methylation data
Dan Luo, Qingling Yang, Haibo Wang et al. (6 authors)
BMC Medical Genomics Open Access
Published: Jan 2021
2 citations
215 days before retraction
Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway
Zongyao Zhang, Xin Yu, Bo Zhou et al. (5 authors)
BioMed Research International Open Access
Published: Aug 2020
38 citations
360 days before retraction
Non-coding RNAs underlying chemoresistance in gastric cancer
Arash Poursheikhani, Zahra Bahmanpour, Ehsan Razmara et al. (9 authors)
Cellular Oncology
Published: Jun 2020
40 citations
432 days before retraction
DUSP2 regulates extracellular vesicle‐VEGF‐C secretion and pancreatic cancer early dissemination
Chu‐An Wang, I-Heng Chang, Pei‐Chi Hou et al. (11 authors)
Journal of Extracellular Vesicles Open Access
Published: Apr 2020
48 citations
492 days before retraction
Noncoding RNAs in gastric cancer: implications for drug resistance
Ling Wei, Jujie Sun, Nasha Zhang et al. (10 authors)
Molecular Cancer Open Access
Published: Mar 2020
406 citations
508 days before retraction
Downregulation of extracellular vesicle microRNA‑101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression
Yuu Saitoh, Tomohiro Umezu, Satoshi Imanishi et al. (12 authors)
Oncology Letters Open Access
Published: Jan 2020
6 citations
578 days before retraction
Non-coding RNA in drug resistance of gastric cancer
Yajun Luo, Qingmei Huang, Yan Ren et al. (7 authors)
World Journal of Gastrointestinal Oncology Open Access
Published: Nov 2019
22 citations
633 days before retraction
Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review)
Chao Chen, Xiaohuan Tang, Yuanda Liu et al. (5 authors)
International Journal of Oncology Open Access
Published: Mar 2019
39 citations
875 days before retraction
Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies
Alessandra Raimondi, Federico Nichetti, Giorgia Peverelli et al. (6 authors)
Pharmacogenomics
Published: Jul 2018
22 citations
1111 days before retraction
Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs
Srinivas V. Koduru, Ashley N. Leberfinger, Yuka Imamura Kawasawa et al. (7 authors)
Scientific Reports Open Access
Published: May 2018
39 citations
1181 days before retraction
MiR-101: a potential therapeutic target of cancers.
Cenzhu Wang, Fei Deng, Hao Li et al. (7 authors)
PubMed
Published: Jan 2018
57 citations
1316 days before retraction
In vitro Evidence on Associations between MicroRNAs and Response to Therapy in Gastric Cancer: Report from the Encyclopedia Amlashica Systematic Reviews
Saeed Taheri
Madridge Journal of Cancer Study & Research Open Access
Published: Nov 2017
2 citations
1370 days before retraction
Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy (Review)
Hani Choudhry, Mazin Zamzami, Ziad Omran et al. (7 authors)
Oncology Letters Open Access
Published: Oct 2017
13 citations
1379 days before retraction
Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer
Wanli Yang, Jiaojiao Ma, Wei Zhou et al. (10 authors)
Expert Opinion on Therapeutic Targets
Published: Oct 2017
51 citations
1399 days before retraction
Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo
Wei Feng, Xin Jiang, Haoyue Gao et al. (4 authors)
International Journal of Oncology Open Access
Published: Sep 2017
101 citations
1417 days before retraction
1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p
Yingyu Ma, Wei Luo, Brittany Bunch et al. (6 authors)
Oncotarget Open Access
Published: Jul 2017
9 citations
1474 days before retraction
An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cells
Zuwen Zhang, Jumei Zhao, Qiuxia Pang et al. (6 authors)
Molecular Medicine Reports Open Access
Published: Feb 2017
6 citations
1650 days before retraction
Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
Bernhard Biersack
Non-coding RNA Research Open Access
Published: Oct 2016
12 citations
1758 days before retraction
Quick Stats
Total Citations: 24
Years Since Retraction: 4.3 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
AKR1C1 alleviates LPS-induced ALI in mice by activating the…
Molecular Medicine Reports • 13 citations
Tan IIA inhibits H1299 cell viability through the MDM4-IAP3…
Molecular Medicine Reports • 17 citations
Tanshinone IIA improves hypoxic ischemic encephalopathy thr…
Molecular Medicine Reports • 26 citations
NG25, an inhibitor of transforming growth factor-β-activate…
Molecular Medicine Reports • 10 citations
Limb remote ischemic post-conditioning reduces injury and i…
Molecular Medicine Reports • 18 citations